Open access
Open access
Powered by Google Translator Translator

Neurology

Review: Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019

1 Jun, 2020 | 03:55h | UTC

Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review – JAMA Neurology

Commentary: Expert reaction a review and a case study looking at neurological manifestations associated with COVID-19 disease and other coronaviruses – Science Media Centre

Related: A Review of Neurological Complications of COVID-19 – Cureus

 

Unruptured Intracranial Aneurysms: Pathogenesis and Individualized Management

1 Jun, 2020 | 03:39h | UTC

Unruptured Intracranial Aneurysms: Pathogenesis and individualized management – Deutsches Ärzteblatt International

 

Randomized Trial: Comparison of 3 Treatment Strategies for Medication Overuse Headache

28 May, 2020 | 09:40h | UTC

Comparison of 3 Treatment Strategies for Medication Overuse Headache: A Randomized Clinical Trial – JAMA Neurology (free for a limited period)

 

Analysis of Traumatic Brain Injury Lesions on Head CT Using Deep Learning

26 May, 2020 | 09:23h | UTC

Multiclass semantic segmentation and quantification of traumatic brain injury lesions on head CT using deep learning: an algorithm development and multicentre validation study – The Lancet Digital Health

Commentaries: Deep learning: a turning point in acute neurology – The Lancet Digital Health

AI successfully used to identify different types of brain injuries – University of Cambridge AND Deep learning automatically measures key features of TBI – Health Imaging

 

[Abstract Only] Randomized Trial: Haloperidol Effective for the Treatment of Headache in the Emergency Department

25 May, 2020 | 01:33h | UTC

Treatment of Headache in the Emergency Department: Haloperidol in the Acute Setting (THE-HA Study): A Randomized Clinical Trial – The Journal of Emergency Medicine

 

SARS2-CoV-2 and Stroke in a New York Healthcare System

22 May, 2020 | 04:56h | UTC

SARS2-CoV-2 and Stroke in a New York Healthcare System – Stroke

News Release: Stroke rates among COVID-19 patients are low, but cases are more severe; overall stroke hospital admissions are down globally – American Heart Association

Commentary: COVID-19 patients may have lower stroke rates than previously suggested – NYU Grossman School of Medicine

 

Neurologic Complications of COVID-19

21 May, 2020 | 09:15h | UTC

Neurologic complications of COVID-19 – American Journal of Emergency Medicine

Related: Neurologic Features in Severe SARS-CoV-2 Infection – New England Journal of Medicine AND Neurologic Manifestations Common in Hospitalized Patients with Covid-19 (study and commentaries) AND Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19 – Neurology

 

Thrombolysis with Alteplase 3–4.5 hours After Acute Ischemic Stroke: Trial Reanalysis Adjusted for Baseline Imbalances

21 May, 2020 | 09:09h | UTC

Thrombolysis with alteplase 3–4.5 hours after acute ischaemic stroke: trial reanalysis adjusted for baseline imbalances – BMJ Evidence-Based Medicine

 

Meta-Analysis: Association of Blood Pressure Lowering with Incident Dementia or Cognitive Impairment

20 May, 2020 | 09:45h | UTC

Association of Blood Pressure Lowering With Incident Dementia or Cognitive Impairment: A Systematic Review and Meta-analysis – JAMA (free for a limited period)

Commentary: Controlling blood pressure may reduce dementia risk by 7% – UPI

 

Endovascular Therapy for Acute Ischemic Stroke During the COVID-19 Pandemic

14 May, 2020 | 09:51h | UTC

Endovascular Therapy for Patients With Acute Ischemic Stroke During the COVID-19 Pandemic: A Proposed Algorithm – Stroke

Commentary: Endovascular Therapy for Acute Ischemic Stroke During COVID-19 Pandemic – American College of Cardiology

 

Guidance Statement: Mechanical Thrombectomy in the Era of the COVID-19 Pandemic

11 May, 2020 | 00:32h | UTC

Mechanical Thrombectomy in the Era of the COVID-19 Pandemic: Emergency Preparedness for Neuroscience Teams: A Guidance Statement From the Society of Vascular and Interventional Neurology – Stroke

Commentaries: Guidance for Treating Stroke Patients During COVD-19 Crisis Developed – Boston University School of Medicine AND Mechanical Thrombectomy and Emergency Preparedness Guidance in COVID-19 Era – American College of Cardiology

 

Sharp Drop in Stroke Evaluations During COVID-19 Pandemic

11 May, 2020 | 00:35h | UTC

Collateral Effect of Covid-19 on Stroke Evaluation in the United States – New England Journal of Medicine

Commentary: Stroke evaluations drop by nearly 40% during COVID-19 pandemic – Washington University School of Medicine

 

[Abstract Only] Randomized Trial: Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke

8 May, 2020 | 10:17h | UTC

Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke – New England Journal of Medicine

Commentary: Endovascular thrombectomy alone noninferior in ischemic stroke – MedicalXpress

 

Report: Management of Ischemic Stroke in Patients with COVID-19

6 May, 2020 | 03:45h | UTC

Management of acute ischemic stroke in patients with COVID-19 infection: Report of an international panel – International Journal of Stroke

 

Case Series: Characteristics of Ischemic Stroke Associated with COVID-19

3 May, 2020 | 22:18h | UTC

Characteristics of ischaemic stroke associated with COVID-19 – Journal of Neurology, Neurosurgery, and Psychiatry

Commentary: Expert reaction to study looking at COVID-19, ischaemic stroke and blood clots – Science media Centre

Related: Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young – New England Journal of Medicine AND Coronavirus’s new mystery: It’s causing strokes in healthy people – Vox AND What’s Behind the Sharp Increase in Large-Vessel Stroke Risk in Young, Healthy COVID-19 Patients? – Neurology Today

 

Review: Neurologic Comorbidities and Complications in Patients Hospitalized for COVID-19

1 May, 2020 | 03:03h | UTC

Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19 – Neurology

Related Studies: Neurologic Features in Severe SARS-CoV-2 Infection – New England Journal of Medicine AND Neurologic Manifestations Common in Hospitalized Patients with Covid-19 (study and commentaries)

 

COVID-19: ICU Delirium Management During SARS-CoV-2 Pandemic

1 May, 2020 | 02:54h | UTC

COVID-19: ICU delirium management during SARS-CoV-2 pandemic – Critical Care

 

AAN Recommendations for Closure of Patent Foramen Ovale in Secondary Stroke Prevention

1 May, 2020 | 02:34h | UTC

Practice advisory update summary: Patent foramen ovale and secondary stroke prevention: Report of the Guideline Subcommittee of the American Academy of Neurology

News Release: AAN updates recommendation on closure of common heart defect after stroke – American Academy of Neurology

 

Systematic Review: No Evidence to Support the Use of Aspirin for the Prevention of Dementia

1 May, 2020 | 02:38h | UTC

Aspirin and other non‐steroidal anti‐inflammatory drugs for the prevention of dementia – Cochrane Library

Summary: Aspirin and other non-steroidal anti-inflammatory drugs for the prevention of dementia – Cochrane Library

Related Randomized Trial: Aspirin Not Beneficial for Reducing the Risk of Dementia, MCI, or Cognitive Decline

 

Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young

29 Apr, 2020 | 05:21h | UTC

Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young – New England Journal of Medicine

 

Miller Fisher Syndrome and Polyneuritis Cranialis in COVID-19

21 Apr, 2020 | 08:03h | UTC

Miller Fisher Syndrome and polyneuritis cranialis in COVID-19 – Neurology

 

Study: Neurologic Manifestations Common in Hospitalized Patients with Covid-19

13 Apr, 2020 | 00:25h | UTC

Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China – JAMA Neurology

Editorial: The Spectrum of Neurologic Disease in the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic Infection: Neurologists Move to the Frontlines

Commentaries: 40% of people with severe COVID-19 experience neurological complications – UPI AND AND Expert reaction to paper on neurological manifestations of patients hospitalised with COVID-19 in Wuhan, China – Science Media Centre

Related: Preparing a neurology department for SARS-CoV-2 (COVID-19): Early experiences at Columbia University Irving Medical Center and the New York Presbyterian Hospital in New York City – Neurology

 

Clinical Practice Guideline: Ménière’s Disease

10 Apr, 2020 | 02:45h | UTC

Clinical Practice Guideline: Ménière’s Disease – Otolaryngology–Head and Neck Surgery

Executive Summary: Clinical Practice Guideline: Ménière’s Disease – Otolaryngology–Head and Neck Surgery

News Release: Ménière’s disease: New clinical practice guideline – American Academy of Otolaryngology

 

Temporary Emergency Guidance to US Stroke Centers During the COVID-19 Pandemic

3 Apr, 2020 | 04:20h | UTC

Temporary Emergency Guidance to US Stroke Centers During the COVID-19 Pandemic – American Heart Association / American Stroke Association

News Release: Interim guidance issued on stroke care during COVID-19 pandemic – American Heart Association

 

[Abstract Only] Randomized Trial: Efficacy of Levetiracetam, Fosphenytoin, and Valproate for Established Status Epilepticus by Age Group

2 Apr, 2020 | 03:54h | UTC

Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial – The Lancet (link to abstract – $ for full-text)

Source: Grupo UTIclínica – HCFMUSP

 

Related Commentary on Twitter

 

Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.